Praised by clients as an ‘extremely experienced and very well-established’ team, Bristows LLP’s one-stop shop is notable for its capabilities in handling technology, life science and consumer products. The team is involved in cutting-edge work in SEP/FRAND cases, alongside pharmaceuticals, including important biologics and antibodies cases. On the transactional side, the team routinely handles IP deals including settlements, high value research collaboration and licensing deals, and IP aspects of corporate and JV transactions. Andrew Bowler and Myles Jelf jointly lead the patent litigation practice, the former is well-versed in coordinating global litigation and the latter is noted for his expertise in telecommunication and high tech matters. Matthew Warren leads the transactional side of the practice, his most notable work includes a landmark research collaboration and licence agreement between Oxford University Innovation and AstraZeneca. Claire Smith is another name to note on the transactional side. Liz Cohen’s strengths lie in the realm of life sciences, while James Boon is sought after by clients in the telecoms and high-tech sectors. Other patent litigation specialists include Gemma Barrett, Richard Pinckney, Robert Burrows, Dominic Adair and Brian Cordery.
Testimonials
Collated independently by Legal 500 research team.
‘Bristows has an extremely experienced and very well-established IP team within a full-service firm - providing excellent support to all aspects of a case.’
‘Quality is at the heart of everything Bristows does.'
- 'Stand-out partners are Myles Jelf and Richard Pinckney.'
‘Myles Jelf, Richard Pinkney and James Boon are all fiercely bright and really know their stuff in respect of telecoms and high category technical litigation. They foster teams that work hard and deliver the highest and most exacting standards. Always a pleasure to work with.'
'They are involved with most of the high-profile litigation in this area and have an impressive client base.’
‘Bristows has an exceptionally strong team of patent litigators, with excellent individuals at both at partner and associate level. In my view it remains in the top patent litigation firms in the UK.’
‘Very personal advice. Adapted to our very specific business.’
‘They always try to find the best solution to our issues.’
Key clients
- Novartis
- Sandoz
- Siemens
- Philips
- Teva
- IPCom
- Scientific Drilling International
- Prysmian
- AstraZeneca
- Carrick Therapeutics
Work highlights
- Advising on a critical, high profile patent deal between AstraZeneca and RQ Bio to license-in new antibodies (developed in collaboration with Oxford University) to produce treatments to protect vulnerable people against new variants of Covid-19.
- Advised Novartis on high-profile patent litigation relating to blockbuster medicine Gilenya, involving successfully arguing (for the first time) that a patentee can apply for interim injunctive relief before patent grant.
- Advised Siemens Gamesa in relation to two prominent UK patent litigation cases which formed part of a global battle (a so-called “clash of the titans”) between it and General Electric in the increasingly important field of wind turbine technology. Wind energy is a crucial part of the UK’s energy policy for the future.
Lawyers
Practice head
The lawyer(s) leading their teams.
Andrew Bowler, Myles Jeff, Matthew Warren